Jorn Aldag does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include HOOKIPA Pharma Inc., and Unum Therapeutics Inc..
2019 was Jorn Aldag's most active year for acquiring shares with 6 total transactions. Jorn Aldag's most active month to acquire stocks was the month of March. 2022 saw Jorn Aldag paying a total of $263,031.00 for 638,177 shares, this is the most they've acquired in one year.